Bloomage BioTechnology Corporation Limited (SHA:688363)

China · Delayed Price · Currency is CNY

43.00

-0.96 (-2.18%)

At close: Mar 20, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	4.22B	5.37B	6.08B	6.36B	4.95B
Pharmaceutical Manufacturing Growth	-21.49%	-11.61%	-4.45%	28.53%	87.93%
Total	4.22B	5.37B	6.08B	6.36B	4.95B
Total Growth	-21.49%	-11.61%	-4.45%	28.53%	87.93%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	6.65B	7.56B	8.57B	6.46B
Mainland China Growth	-12.03%	-11.80%	32.50%	90.80%
Other Countries or Regions	366.16M	420.91M	361.49M	579.43M
Other Countries or Regions Growth	-13.01%	16.44%	-37.61%	43.77%
Offset	-1.69B	-1.96B	-2.60B	-2.12B
Hong Kong	48.90M	54.52M	35.30M	27.96M
Hong Kong Growth	-10.32%	54.47%	26.22%	40.62%
Total	5.37B	6.08B	6.36B	4.95B
Total Growth	-11.60%	-4.46%	28.53%	87.99%

Source: S&P Global Market Intelligence.